Agora financial pitching the 1500 retirement loopholeAnyone familiar with this ? Guaranteed 1500 a month on 2 or 3 clicks a month. Pitched by Chris Campbell http://research.agorafinancial.com/research/html/tia_retireloop_1214/?code=ETIARC16&ver=9&o=35496&s=36337&u=4734055&l=111989&g=0&r=MC2&a=13&email=hywaylaw@gmail.com&n=TIA_disloop_1215
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
Anybody with insight into the Money Map Press groups newest urgent tease regarding a $3 stock that has an upcoming announcement, that will make us all millionaires, for treating tinnitus?
Is it Auris Medical Holding AG (EARS)? Was $3.00-$3.50 till recently. Has run up because of the promo.
That looks reasonable Joe. I think we need the thinkolator in on this one.
Thinkolator already answered at the end of the last article of the year. Has been a great trader.
What is the post dated? I’m not finding it at the end of December 2015 or was it posted prior to Christmas?
Thanks
I have spent the better part of 3 hours on the site searching for the answer you state was posted at the end of the last article of the year. Is this content only available to paid subscribers? Great reading but I was attempting to find the info you are referring to in your post.
Yes. It is most likely EARS. OTIC is priced in the $20s/share and is in San Diego. Both are recent IPOS from 2014 and don’t believe OTIC was ever that low even from the onset.
Yes, we need the thinkolator on this one
Thinkolator already answered at the end of the last article of the year. Has been a great trader.
This is what wrote before xmas, just FYI:
P.P.S. OK, OK, for all those who are asking this morning: A quick teaser answer. The Money Map Press folks are selling their $5,900 Passport Club service (lifetime access to all their newsletters for one price) by pitching what they call a “remarkable new Tinnitus drug recommendation we’re reserving for our most loyal readers… The little $4 stock that could be on a path to $911 once Phase 3 study results are announced early next year.” I’ve done no analysis of it at all, but the stock they’re teasing is pretty clearly Auris (EARS). Which is already up 25% or so at the open today, so lots of folks already figured that out. Is it really worth a look? Discuss among yourselves….